Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib.
Hamberg
Paul
P
de Jong
Floris A
FA
Boonstra
Joke G
JG
van Doorn
Jaap
J
Verweij
Jaap
J
Sleijfer
Stefan
S
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology* / Q000378:metabolism; D000068877:Imatinib Mesylate; D007335:Insulin-Like Growth Factor II / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011498:Protein Precursors / Q000378:metabolism; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011498:Protein Precursors; D011743:Pyrimidines; C066038:proinsulin-like growth factor II; D007335:Insulin-Like Growth Factor II; D000068877:Imatinib Mesylate